Variant report
Variant | esv3478822 |
---|---|
Chromosome Location | chr8:8385885-8386989 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112931741 | chr8:8385918-8385919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188949669 | chr8:8386000-8386001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536040753 | chr8:8386007-8386008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555487856 | chr8:8386009-8386010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs572185747 | chr8:8386018-8386019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs373185316 | chr8:8386039-8386040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181491673 | chr8:8386042-8386043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557698454 | chr8:8386050-8386051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576751436 | chr8:8386059-8386060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7845897 | chr8:8386073-8386074 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs114204351 | chr8:8386074-8386075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115057189 | chr8:8386125-8386126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541984250 | chr8:8386128-8386129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369932606 | chr8:8386193-8386194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146872564 | chr8:8386209-8386210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs140689523 | chr8:8386241-8386242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547437364 | chr8:8386243-8386244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185740179 | chr8:8386258-8386259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533686721 | chr8:8386278-8386279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs145786791 | chr8:8386284-8386285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138329566 | chr8:8386298-8386299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs140965919 | chr8:8386301-8386302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549150670 | chr8:8386330-8386331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541853441 | chr8:8386346-8386347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs117212397 | chr8:8386352-8386353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190267297 | chr8:8386359-8386360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537449116 | chr8:8386388-8386389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549427053 | chr8:8386389-8386390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7835490 | chr8:8386427-8386428 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs576269230 | chr8:8386442-8386443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs57446549 | chr8:8386448-8386449 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs561837317 | chr8:8386510-8386511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150196980 | chr8:8386524-8386525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374558225 | chr8:8386527-8386528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138738836 | chr8:8386550-8386551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573573050 | chr8:8386604-8386605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532837814 | chr8:8386623-8386624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181035480 | chr8:8386635-8386636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542481285 | chr8:8386674-8386675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs555935851 | chr8:8386701-8386702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529557332 | chr8:8386712-8386713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549189705 | chr8:8386742-8386743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs377691987 | chr8:8386746-8386747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371293776 | chr8:8386797-8386798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548451966 | chr8:8386805-8386806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373530255 | chr8:8386826-8386827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139234407 | chr8:8386827-8386828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386412006 | chr8:8386829-8386830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10677125 | chr8:8386831-8386832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71513200 | chr8:8386834-8386835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:8374600-8387400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:8376000-8388000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:8380600-8387200 | Weak transcription | Fetal Heart | heart |
4 | chr8:8382000-8386400 | Weak transcription | HepG2 | liver |
5 | chr8:8382400-8388000 | Weak transcription | Fetal Lung | lung |
6 | chr8:8382600-8388000 | Weak transcription | Liver | Liver |
7 | chr8:8382800-8387800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr8:8382800-8388000 | Weak transcription | Placenta Amnion | Placenta Amnion |
9 | chr8:8384800-8388000 | Weak transcription | A549 | lung |
10 | chr8:8385200-8386000 | Enhancers | Placenta | Placenta |
11 | chr8:8385200-8387200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr8:8385200-8388000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
13 | chr8:8385200-8388600 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr8:8385400-8387200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr8:8385400-8387800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
16 | chr8:8385400-8388000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
17 | chr8:8385400-8388000 | Weak transcription | HSMM | muscle |
18 | chr8:8385400-8388000 | Weak transcription | NH-A | brain |
19 | chr8:8385400-8388000 | Weak transcription | Osteobl | bone |
20 | chr8:8385400-8388200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr8:8385600-8387400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
22 | chr8:8385600-8387400 | Weak transcription | HSMMtube | muscle |
23 | chr8:8385600-8387600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
24 | chr8:8385600-8387600 | Weak transcription | Brain Germinal Matrix | brain |
25 | chr8:8385600-8389000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
26 | chr8:8385600-8394000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
27 | chr8:8385800-8387400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
28 | chr8:8386000-8387800 | Weak transcription | Placenta | Placenta |
29 | chr8:8386400-8386600 | Enhancers | HepG2 | liver |
30 | chr8:8386600-8387000 | Weak transcription | HepG2 | liver |
31 | chr8:8386600-8389200 | Enhancers | Ovary | ovary |